Current Concepts in Head and Neck Surgery

---

LIVEABOHNSHeadNeckSurgery

Friday, November 13, 2026, 12:00 PM - Saturday, November 14, 2026, 4:00 PM, MD Anderson - Onstead Auditorium, Houston, TX


AMA PRA Category 1 Credits™ (11.50 hours), ABOHNS MOC Part II (11.50 hours), Non-Physician Attendance (11.50 hours)

This two day course, building on the long standing tri institutional Current Concepts series, will review contemporary management of head and neck tumors with a focus on surgical approaches, multidisciplinary care, functional outcomes, emerging technologies, and novel systemic strategies in thyroid cancer. Esteemed faculty from three major cancer centers — MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, and the University of Toronto — will review the current epidemiology and management of oral cavity, oropharynx, larynx/hypopharynx, skin, thyroid/parathyroid, salivary gland, and skull base tumors; discuss multidisciplinary decision making in early stage and advanced cancers; and explore strategies for optimizing reconstruction, function, and survivorship. The course will feature a combination of focused presentations, structured debates, and interactive panel discussions. Attendees will have opportunities to engage with faculty throughout the program and to discuss challenging cases in a multidisciplinary “Stump the Faculty” / tumor board format.

1. Apply current evidence from neoadjuvant and adjuvant head and neck cancer trials to identify appropriate referral timing to tertiary centers.
2. Develop treatment plans aligned with contemporary guideline-based indications and multidisciplinary standards or care.
3. Describe contemporary strategies for sequencing surgery with systemic and radiation therapy following neoadjuvant treatment
4. Identify advanced minimally invasive and ablative techniques that may benefit appropriately selected patients with head and neck cancers.

Current Concepts in Head & Neck Surgery will be held November 13–14, 2026, at Onstead Auditorium, MD Anderson Cancer Center, located in the Mitchell Building (BSRB), Floor 3, 6767 Bertner Avenue, Houston, Texas. The conference will begin on Friday, November 13, 2026, and conclude on Saturday, November 14, 2026. The deadline for advanced registration is October 16, 2026.

Location: Onstead Auditorium, MD Anderson Cancer Center, located in the Mitchell Building (BSRB), Floor 3, 6767 Bertner Avenue, Houston, Texas.

Registration Category Fees

 

Early registration rates apply through October 16, 2026. Regular registration rates apply beginning October 16, 2026, 12:00 AM (CST).

Payment Information:

Telephone registrations are not accepted.

We accept the following forms of payment:
Credit Cards (MasterCard, VISA, and American Express)
Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
P.O. Box 301407
Houston, Texas 77230-1407

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form. 

Refund/Cancellation Policy
The registration fee, minus a $50 administration-handling fee, is refundable if a written request is received on or before Octoberr 16, 2026, for both activities. No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

For additional information, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail:  [email protected].

Special Assitance
Contact Continuing Professional Education / Activity Management at 713-792-2223 or 866-849-5866. You may also email CPE at [email protected].  

Evaluation:
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.  The survey link will be provided during the review course.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation:

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 11.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Otolaryngology – Head and Neck Surgery’s MOC Credit:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the educational content of a certified continuing education (CE) activity, including faculty, planners, reviewers, are required to disclose all financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used on or by patients. All relevant financial relationships have been mitigated prior to the start of the activity.

W9 Form Exhibit at this Event